Source: EIN Presswire

Press Release: Celmatix : Celmatix Nominates First Lead Compound in Oral Fertility Drug Program

NEW YORK, NY, UNITED STATES, October 22, 2024 /⁨EINPresswire.com⁩/ -- Celmatix Inc., the leading women's health biotechnology company focused on ovarian biology, has announced the nomination of a lead compound in its oral Follicle Stimulating Hormone ...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Piraye Yurttas Beim's photo - Founder & CEO of Celmatix

Founder & CEO

Piraye Yurttas Beim

CEO Approval Rating

70/100

Read more